Physician profile
James M Losito
NPI 1124015128
$5,111.80
in general payments reported to CMS, 2019-2025
42 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Sports Medicine (Podiatrist) provider received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,086 · 2020: $1,050 · 2021: $640 · 2022: $521 · 2023: $772 · 2024: $338 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,714 · Travel and Lodging: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,713.90 |
| Travel and Lodging | $101.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $821.26 | 2019-2025 | Salvation, Ortholoc 3di, Augment Injectable |
| Organogenesis INC. | $596.54 | 2020-2024 | Puraply, Puraply Am |
| Horizon Therapeutics Plc | $463.12 | 2019-2022 | |
| Arthrex, INC. | $461.00 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $416.28 | 2020-2021 | |
| Biotissue Holdings INC. | $292.33 | 2019 | |
| Polynovo North America LLC | $288.85 | 2022-2025 | Novosorb Btm |
| Aroa Biosurgery Incorporated | $169.99 | 2023 | |
| Smith+Nephew, INC. | $168.98 | 2019-2024 | Collagenase Santyl, Pico 14 |
| Depuy Synthes Sales INC. | $151.87 | 2020-2025 | |
| Bioventus LLC | $124.80 | 2023-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Treace Medical Concepts, INC. | $124.44 | 2025 | |
| Biocomposites INC | $100.00 | 2021 | |
| Averitas Pharma INC. | $80.56 | 2024-2025 | Qutenza |
| Cardiovascular Systems INC. | $77.22 | 2019-2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $51.25 | 2021-2024 | Nuzyra |
| Kerecis Limited | $47.83 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Wright Medical Technology, INC. | $47.11 | 2019 | |
| Amgen INC. | $46.04 | 2024 | Krystexxa |
| Acumed LLC | $44.40 | 2022 | |
| Integra Lifesciences Corporation | $43.36 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $41.17 | 2024 | |
| Kci USA, INC. | $38.43 | 2020-2021 | |
| Axogen | $37.35 | 2023 | Avance Nerve Graft |
| Sebela Pharmaceuticals INC. | $31.93 | 2022 | |
| Zimmer Biomet Holdings, INC. | $28.45 | 2019-2021 | |
| Orthofix Medical, INC. | $25.34 | 2019 | |
| Djo, LLC | $25.06 | 2020 | |
| Abbvie INC. | $24.97 | 2024 | |
| Innovation Technologies INC | $24.19 | 2022 | |
| Electronic Waveform Lab, INC. | $23.72 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $23.28 | 2019 | |
| Abbott Laboratories | $21.79 | 2025 | Esprit |
| Sanara Medtech INC. | $21.25 | 2024 | Celleraterx |
| Acell, INC. | $18.34 | 2019 | |
| Merck Sharp & Dohme LLC | $18.25 | 2019 | |
| Nevro Corp. | $17.83 | 2023 | Senza |
| Alfasigma USA, INC. | $17.28 | 2021 | |
| Amniox Medical, INC. | $16.48 | 2020 | |
| Access Pro Medical, LLC | $15.58 | 2025 | Matriderm |
| Stimwave Technologies Incorporated | $12.14 | 2020 | |
| Paragon 28, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Losito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.